These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22028220)

  • 1. Greater effect of stroke thrombolysis in the presence of arterial obstruction.
    De Silva DA; Churilov L; Olivot JM; Christensen S; Lansberg MG; Mlynash M; Campbell BC; Desmond P; Straka M; Bammer R; Albers GW; Davis SM; Donnan GA;
    Ann Neurol; 2011 Oct; 70(4):601-5. PubMed ID: 22028220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET).
    De Silva DA; Brekenfeld C; Ebinger M; Christensen S; Barber PA; Butcher KS; Levi CR; Parsons MW; Bladin CF; Donnan GA; Davis SM;
    Stroke; 2010 Feb; 41(2):295-9. PubMed ID: 20056931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis.
    Parsons MW; Christensen S; McElduff P; Levi CR; Butcher KS; De Silva DA; Ebinger M; Barber PA; Bladin C; Donnan GA; Davis SM;
    J Cereb Blood Flow Metab; 2010 Jun; 30(6):1214-25. PubMed ID: 20087363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.
    Davis SM; Donnan GA; Parsons MW; Levi C; Butcher KS; Peeters A; Barber PA; Bladin C; De Silva DA; Byrnes G; Chalk JB; Fink JN; Kimber TE; Schultz D; Hand PJ; Frayne J; Hankey G; Muir K; Gerraty R; Tress BM; Desmond PM;
    Lancet Neurol; 2008 Apr; 7(4):299-309. PubMed ID: 18296121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation.
    Tu HT; Campbell BC; Christensen S; Desmond PM; De Silva DA; Parsons MW; Churilov L; Lansberg MG; Mlynash M; Olivot JM; Straka M; Bammer R; Albers GW; Donnan GA; Davis SM;
    Int J Stroke; 2015 Jun; 10(4):534-40. PubMed ID: 23489996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative diffusion-weighted imaging after intravenous tissue-type plasminogen activator is rare and unlikely to indicate averted infarction.
    Freeman JW; Luby M; Merino JG; Latour LL; Auh S; Song SS; Magadán A; Lynch JK; Warach S; Hsia AW
    Stroke; 2013 Jun; 44(6):1629-34. PubMed ID: 23572476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours.
    Röther J; Schellinger PD; Gass A; Siebler M; Villringer A; Fiebach JB; Fiehler J; Jansen O; Kucinski T; Schoder V; Szabo K; Junge-Hülsing GJ; Hennerici M; Zeumer H; Sartor K; Weiller C; Hacke W;
    Stroke; 2002 Oct; 33(10):2438-45. PubMed ID: 12364735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of arterial occlusion on outcome after intravenous thrombolysis for acute ischemic stroke.
    Medlin F; Amiguet M; Vanacker P; Michel P
    Stroke; 2015 Jan; 46(1):126-31. PubMed ID: 25424477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reperfusion after 4.5 hours reduces infarct growth and improves clinical outcomes.
    Picanço MR; Christensen S; Campbell BC; Churilov L; Parsons MW; Desmond PM; Barber PA; Levi CR; Bladin CF; Donnan GA; Davis SM;
    Int J Stroke; 2014 Apr; 9(3):266-9. PubMed ID: 24256139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Diffusion Lesion Volume Above 70 mL Preclude Favorable Outcome Despite Post-Thrombolysis Recanalization?
    Tisserand M; Turc G; Charron S; Legrand L; Edjlali M; Seners P; Roca P; Lion S; Naggara O; Mas JL; Méder JF; Baron JC; Oppenheim C
    Stroke; 2016 Apr; 47(4):1005-11. PubMed ID: 26979862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke.
    Parsons MW; Barber PA; Chalk J; Darby DG; Rose S; Desmond PM; Gerraty RP; Tress BM; Wright PM; Donnan GA; Davis SM
    Ann Neurol; 2002 Jan; 51(1):28-37. PubMed ID: 11782981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Thrombolysis Increases the Rate of Dramatic Recovery in Patients with Acute Stroke with an Unknown Onset Time and Negative FLAIR MRI.
    Aoki J; Sakamoto Y; Kimura K
    J Neuroimaging; 2016 Jul; 26(4):414-9. PubMed ID: 27388586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study.
    Rubiera M; Ribo M; Pagola J; Coscojuela P; Rodriguez-Luna D; Maisterra O; Ibarra B; Piñeiro S; Meler P; Romero FJ; Alvarez-Sabin J; Molina CA
    Stroke; 2011 Apr; 42(4):993-7. PubMed ID: 21372307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of symptomatic intracerebral hemorrhage in patients treated with intra-arterial thrombolysis.
    Singer OC; Berkefeld J; Lorenz MW; Fiehler J; Albers GW; Lansberg MG; Kastrup A; Rovira A; Liebeskind DS; Gass A; Rosso C; Derex L; Kim JS; Neumann-Haefelin T;
    Cerebrovasc Dis; 2009; 27(4):368-74. PubMed ID: 19218803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke.
    Savitz SI; Schlaug G; Caplan L; Selim M
    Stroke; 2005 Jul; 36(7):1447-51. PubMed ID: 15947268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
    Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
    J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch.
    Chemmanam T; Campbell BC; Christensen S; Nagakane Y; Desmond PM; Bladin CF; Parsons MW; Levi CR; Barber PA; Donnan GA; Davis SM;
    Neurology; 2010 Sep; 75(12):1040-7. PubMed ID: 20720188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infarct growth with and without intravenous thrombolysis in acute ischemic stroke.
    Baizabal-Carvallo JF
    Ann Neurol; 2012 Mar; 71(3):433; author reply 433-4. PubMed ID: 22451210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.